Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9118 |
High Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8777 |
High Similarity |
NPD5404 |
Approved |
0.8777 |
High Similarity |
NPD5406 |
Approved |
0.8777 |
High Similarity |
NPD5408 |
Approved |
0.8777 |
High Similarity |
NPD5405 |
Approved |
0.8722 |
High Similarity |
NPD1470 |
Approved |
0.8446 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8421 |
Intermediate Similarity |
NPD1201 |
Approved |
0.8356 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8309 |
Intermediate Similarity |
NPD1164 |
Approved |
0.8194 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8106 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.8089 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.805 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8028 |
Intermediate Similarity |
NPD943 |
Approved |
0.7871 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7808 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7762 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7742 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7718 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7697 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7697 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD5951 |
Approved |
0.7671 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7667 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7651 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7634 |
Intermediate Similarity |
NPD74 |
Approved |
0.7634 |
Intermediate Similarity |
NPD9266 |
Approved |
0.761 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7609 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7584 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7574 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7568 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7557 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7557 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7557 |
Intermediate Similarity |
NPD9267 |
Approved |
0.755 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7546 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7536 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD1240 |
Approved |
0.75 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7469 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7465 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7413 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7399 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7391 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7368 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7357 |
Intermediate Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7329 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7303 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7293 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7293 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD411 |
Approved |
0.7267 |
Intermediate Similarity |
NPD8438 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7252 |
Intermediate Similarity |
NPD9261 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7219 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7208 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7203 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7192 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7184 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD3026 |
Approved |
0.7183 |
Intermediate Similarity |
NPD3023 |
Approved |
0.7179 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7172 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7172 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7171 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7163 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7163 |
Intermediate Similarity |
NPD3025 |
Approved |
0.7163 |
Intermediate Similarity |
NPD3024 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7121 |
Intermediate Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.7121 |
Intermediate Similarity |
NPD1929 |
Approved |
0.7121 |
Intermediate Similarity |
NPD1930 |
Approved |
0.7108 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7108 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7099 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7095 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7093 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7092 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7089 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7089 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7083 |
Intermediate Similarity |
NPD3972 |
Approved |
0.707 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7067 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7045 |
Intermediate Similarity |
NPD1932 |
Approved |
0.7042 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7032 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7032 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7029 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7027 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7022 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7022 |
Intermediate Similarity |
NPD6535 |
Approved |
0.702 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7018 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7 |
Intermediate Similarity |
NPD6020 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6994 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD1876 |
Approved |
0.6985 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD7008 |
Discontinued |
0.6977 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6966 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6966 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6957 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6957 |
Remote Similarity |
NPD8319 |
Approved |
0.6954 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6951 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6941 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6937 |
Remote Similarity |
NPD920 |
Approved |
0.6923 |
Remote Similarity |
NPD6776 |
Approved |
0.6923 |
Remote Similarity |
NPD6779 |
Approved |
0.6923 |
Remote Similarity |
NPD6781 |
Approved |
0.6923 |
Remote Similarity |
NPD6782 |
Approved |
0.6923 |
Remote Similarity |
NPD5691 |
Approved |
0.6923 |
Remote Similarity |
NPD6778 |
Approved |
0.6923 |
Remote Similarity |
NPD6780 |
Approved |
0.6923 |
Remote Similarity |
NPD6777 |
Approved |
0.6918 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6906 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6906 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6887 |
Remote Similarity |
NPD520 |
Approved |
0.6886 |
Remote Similarity |
NPD5494 |
Approved |
0.6875 |
Remote Similarity |
NPD2286 |
Discontinued |
0.6867 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6861 |
Remote Similarity |
NPD2329 |
Discontinued |
0.6849 |
Remote Similarity |
NPD4878 |
Approved |
0.6849 |
Remote Similarity |
NPD1608 |
Approved |
0.6848 |
Remote Similarity |
NPD2296 |
Approved |
0.6842 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6842 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6839 |
Remote Similarity |
NPD2438 |
Suspended |
0.6839 |
Remote Similarity |
NPD6100 |
Approved |
0.6839 |
Remote Similarity |
NPD6099 |
Approved |
0.6835 |
Remote Similarity |
NPD6190 |
Approved |
0.6832 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6813 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6811 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6811 |
Remote Similarity |
NPD7698 |
Approved |
0.6811 |
Remote Similarity |
NPD7697 |
Approved |
0.681 |
Remote Similarity |
NPD6585 |
Discontinued |
0.6809 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6805 |
Remote Similarity |
NPD6808 |
Phase 2 |
0.6802 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6797 |
Remote Similarity |
NPD1933 |
Approved |
0.6792 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6781 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6774 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6774 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6772 |
Remote Similarity |
NPD3400 |
Discontinued |
0.6772 |
Remote Similarity |
NPD7874 |
Approved |
0.6772 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6768 |
Remote Similarity |
NPD5889 |
Approved |
0.6768
|
Remote Similarity |
NPD5890 |
Approved |